Commercializing cognitive neurotechnology—the ethical terrain

Lack of recognition of the ethical, social and policy issues associated with the commercialization of neurotechnology could compromise new ventures in the area.

[1]  I. Wilkinson,et al.  Behavioural and functional anatomical correlates of deception in humans , 2001, Neuroreport.

[2]  J. Moreno.  Neuroethics: an agenda for neuroscience and society , 2003, Nature Reviews Neuroscience.

[3]  M. Greicius,et al.  Prospects for Prediction , 2007, Annals of the New York Academy of Sciences.

[4]  Zhen Lin,et al.  Genomic Research and Human Subject Privacy , 2004, Science.

[5]  Judy Illes,et al.  Neurocognitive enhancement: what can we do and what should we do? , 2004, Nature Reviews Neuroscience.

[6]  John D E Gabrieli,et al.  Control over brain activation and pain learned by using real-time functional MRI. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  N. Sadato,et al.  Reduced responsiveness is an essential feature of chronic fatigue syndrome: A fMRI study , 2006, BMC neurology.

[8]  T. Raffin,et al.  Self-referred whole-body CT imaging: current implications for health care consumers. , 2003, Radiology.

[9]  Samuel M. McClure,et al.  Neural Correlates of Behavioral Preference for Culturally Familiar Drinks , 2004, Neuron.

[10]  J. Illes,et al.  Neuroethics: Dialogue on a Continuum from Tradition to Innovation , 2005 .

[11]  M. Reivich,et al.  Limbic activation during cue-induced cocaine craving. , 1999, The American journal of psychiatry.

[12]  Shawn L. Berman,et al.  Introduction: Special Issue:" Business Ethics in a Global Economy": Hosted by the Santa Clara University Markkula Center for Applied Ethics , 2004 .

[13]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[14]  C. Jack,et al.  MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD , 2003, Neurology.

[15]  Martha J. Farah,et al.  Emerging ethical issues in neuroscience , 2002, Nature Neuroscience.

[16]  A. Anderson,et al.  Effects of hypoglycemia on human brain activation measured with fMRI. , 2006, Magnetic resonance imaging.

[17]  J. Illes,et al.  New prospects and ethical challenges for neuroimaging within and outside the health care system. , 2003, AJNR. American journal of neuroradiology.

[18]  A. Gray.  Stigma in psychiatry. , 2002, Journal of the Royal Society of Medicine.

[19]  Judy Illes,et al.  NEUROETHICS: DEFINING THE ISSUES IN THEORY, PRACTICE, AND POLICY , 2006 .

[20]  J. Illes,et al.  ELSI Priorities for Brain Imaging , 2006, The American journal of bioethics : AJOB.

[21]  T. Canli,et al.  Neuroimaging of emotion and personality: Scientific evidence and ethical considerations , 2002, Brain and Cognition.

[22]  Vincent Giampietro,et al.  Probing the Working Memory System in Chronic Fatigue Syndrome: A Functional Magnetic Resonance Imaging Study Using the n-Back Task , 2006, Psychosomatic medicine.

[23]  Kevin A. Johnson,et al.  Detecting Deception Using Functional Magnetic Resonance Imaging , 2005, Biological Psychiatry.

[24]  Judy Illes,et al.  From neuroimaging to neuroethics , 2003, Nature Neuroscience.

[25]  Chetwyn C. H. Chan,et al.  Lie detection by functional magnetic resonance imaging , 2002, Human brain mapping.

[26]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[27]  Steve Olson.  Brain Scans Raise Privacy Concerns , 2005, Science.

[28]  A. Leshner.  It's Time to Go Public with Neuroethics , 2005, The American journal of bioethics : AJOB.

[29]  P. Maruff,et al.  Computerised neuropsychological testing , 2003, British journal of sports medicine.

[30]  F. Collins.  BRCA1--lots of mutations, lots of dilemmas. , 1996, The New England journal of medicine.

[31]  Steven L. Miller,et al.  Neural deficits in children with dyslexia ameliorated by behavioral remediation: Evidence from functional MRI , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Sayre,et al.  What Treatments are “Satisfactory?” Divining Regulatory Intent and an Ethical Basis for Exception to Informed Consent for Emergency Research , 2006, American Journal of Bioethics.

[33]  William A. Cunningham,et al.  Performance on Indirect Measures of Race Evaluation Predicts Amygdala Activation , 2000, Journal of Cognitive Neuroscience.

[34]  Michael S. Gazzaniga.  The Ethical Brain , 2005 .

[35]  William J. Jagust,et al.  The Use of MRI and PET for Clinical Diagnosis of Dementia and Investigation of Cognitive Impairment : A Consensus Report , 2004 .

[36]  Hannah Hoag.  Neuroengineering: Remote control , 2003, Nature.